Sang Hyun Park1, Dae Han Lee2, Soon Ae Kim3

  • 1Department of Internal Medicine, School of Medicine, Eulji University, Daejeon, Republic of Korea.

In vivo (Athens, Greece)
|February 28, 2024
PubMed
概括

费布里病细胞增加了外体分泌,以控制有毒的全球酸胺 (Gb3) 积累. 用beta-agalsidase的酶替代疗法减少了这种分泌和相关的细胞压力标志物.